The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Sodium salt (5R,6R)-6-((R)-tert-butoxycarbonyl-hydroxy-methyl)-3-tert-butyl-7-oxo-4-oxa-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate ID: ALA432534
PubChem CID: 44310270
Max Phase: Preclinical
Molecular Formula: C16H22NNaO7
Molecular Weight: 341.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)OC(=O)[C@H](O)[C@H]1C(=O)N2C(C(=O)[O-])=C(C(C)(C)C)O[C@H]12.[Na+]
Standard InChI: InChI=1S/C16H23NO7.Na/c1-15(2,3)10-8(13(20)21)17-11(19)7(12(17)23-10)9(18)14(22)24-16(4,5)6;/h7,9,12,18H,1-6H3,(H,20,21);/q;+1/p-1/t7-,9+,12+;/m0./s1
Standard InChI Key: DZJYERSNAGACBN-TTWAZCPVSA-M
Molfile:
RDKit 2D
27 27 0 0 0 0 0 0 0 0999 V2000
5.6042 -8.1250 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
6.4417 -6.5750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2292 -6.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4417 -5.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6167 -6.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6167 -5.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7042 -6.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2167 -5.4917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2292 -5.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4792 -7.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0292 -5.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5292 -6.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0167 -6.1792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0292 -7.1625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6417 -4.7917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8542 -8.3000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2917 -7.7792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2167 -6.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2417 -4.3667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6042 -5.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3042 -6.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9042 -6.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0042 -7.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6417 -5.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9292 -6.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6935 -6.1343 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
6.2815 -4.7629 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
3 2 1 0
4 2 1 0
5 2 1 0
6 5 1 0
7 3 2 0
4 8 1 0
9 11 1 0
10 3 1 0
6 11 1 0
12 7 1 0
13 9 1 0
14 5 2 0
15 9 2 0
16 10 1 0
17 10 2 0
18 13 1 0
11 19 1 6
20 12 1 0
21 12 1 0
22 12 1 0
23 18 1 0
24 18 1 0
25 18 1 0
4 6 1 0
7 8 1 0
6 26 1 1
4 27 1 6
M CHG 2 1 1 16 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 341.36Molecular Weight (Monoisotopic): 341.1475AlogP: 0.85#Rotatable Bonds: 3Polar Surface Area: 113.37Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.65CX Basic pKa: ┄CX LogP: 0.52CX LogD: -2.80Aromatic Rings: ┄Heavy Atoms: 24QED Weighted: 0.58Np Likeness Score: 0.51
References 1. Wild H, Metzger K. (1993) Substituted 6-alkyloxapenems: potent -lactamase inhibitors: synthesis and biological characterization, 3 (11): [10.1016/S0960-894X(01)80926-4 ]